Percutaneous penetration kinetics of nitroglycerin and its dinitrate metabolites across hairless mouse skin in vitro
- PMID: 1796039
- DOI: 10.1023/a:1015887309391
Percutaneous penetration kinetics of nitroglycerin and its dinitrate metabolites across hairless mouse skin in vitro
Abstract
The percutaneous penetration kinetics of the antianginal, nitroglycerin (GTN), and its primary metabolites, 1,2- and 1,3-glyceryl dinitrate (1,2- and 1,3-GDN), were evaluated in vitro, using full-thickness hairless mouse skin. GTN and the 1,2- and 1,3-GDNs were applied (a) in aqueous solution as pH 7.4 phosphate-buffered saline (PBS) and (b) incorporated into lipophilic ointment formulations. The cutaneous transformation of GTN to its dinitrate metabolites was detected, but no interconversion between 1,2-GDN and 1,3-GDN was observed. Following application of the nitrates in PBS solution, all three compounds exhibited steady-state transport kinetics. The steady-state flux of GTN (8.9 +/- 1.5 nmol cm-2 hr-1) was significantly greater (P less than 0.05) than those of 1,2-GDN (0.81 +/- 0.54 nmol cm-2 hr-1) and 1,3-GDN (0.72 +/- 0.20 nmol cm-2 hr-1). The corresponding permeability coefficient (rho) for GTN (20 +/- 3 x 10(-3) cm hr-1) was significantly larger than the corresponding values for 1,2-GDN (1.4 +/- 0.9 x 10(-3) cm hr-1) and 1,3-GDN (1.2 +/- 0.4 x 10(-3) cm hr-1), which were statistically indistinguishable (P greater than 0.05). Further analysis of the transport data showed that the differences between GTN and the GDNs could be explained by the relative stratum corneum/water partition coefficient (Ks) values of the compounds. The apparent partition parameters, defined as kappa = Ks.h [where h is the diffusion path length through stratum corneum (SC)] were 19.8 +/- 2.5 x 10(-2) cm for GTN and 1.91 +/- 1.07 x 10(-2) and 1.81 +/- 0.91 x 10(-2) cm for 1,2- and 1,3-GDN, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Cutaneous metabolism of nitroglycerin in vitro. I. Homogenized versus intact skin.Pharm Res. 1992 Feb;9(2):187-90. doi: 10.1023/a:1018925004345. Pharm Res. 1992. PMID: 1553339
-
Cutaneous metabolism of nitroglycerin in vitro. II. Effects of skin condition and penetration enhancement.Pharm Res. 1992 Mar;9(3):303-6. doi: 10.1023/a:1015822431178. Pharm Res. 1992. PMID: 1614960
-
Pharmacokinetics and pharmacodynamics of nitroglycerin and its dinitrate metabolites in conscious dogs: intravenous infusion studies.J Pharmacokinet Biopharm. 1993 Oct;21(5):533-50. doi: 10.1007/BF01059113. J Pharmacokinet Biopharm. 1993. PMID: 8145130
-
Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.Clin Pharmacokinet. 2003;42(3):205-21. doi: 10.2165/00003088-200342030-00001. Clin Pharmacokinet. 2003. PMID: 12603173 Review.
-
Relevance of hairless mouse as an experimental model of percutaneous penetration in man.Skin Pharmacol Appl Skin Physiol. 1998 Mar-Apr;11(2):80-6. doi: 10.1159/000029812. Skin Pharmacol Appl Skin Physiol. 1998. PMID: 9603658 Review.
Cited by
-
Organic nitrate metabolism and action: toward a unifying hypothesis and the future-a dedication to Professor Leslie Z. Benet.J Pharm Sci. 2013 Sep;102(9):3070-81. doi: 10.1002/jps.23550. Epub 2013 May 13. J Pharm Sci. 2013. PMID: 23670666 Free PMC article. Review.
-
Simultaneous pharmacodynamic modeling of the non-steady-state effects of three oral doses of 1,3-glyceryl dinitrate upon blood pressure in healthy volunteers.J Pharmacokinet Biopharm. 1993 Oct;21(5):515-32. doi: 10.1007/BF01059112. J Pharmacokinet Biopharm. 1993. PMID: 8145129
-
Pharmacokinetic characterisation of transdermal delivery systems.Clin Pharmacokinet. 1994 Feb;26(2):121-34. doi: 10.2165/00003088-199426020-00005. Clin Pharmacokinet. 1994. PMID: 8162656 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources